Table 4.
Correlation between congestion markers on admission and at discharge
Hospital admission | ||||
---|---|---|---|---|
CS | IVCmax | VAS | NT-proBNP | |
CS | 0.09 (− 0.08 to 0.26) | 0.04 (− 0.14 to 0.22) | − 0.07 (− 0.24 to 0.101) | |
IVCmax | 0.09 (− 0.08 to 0.26) | 0.11 (− 0.07 to 0.28) | − 0.09 (− 0.25 to 0.09) | |
VAS | 0.04 (− 0.14 to 0.22) | 0.11 (− 0.07 to 0.28) | 0.04 (− 0.13 to 0.22) | |
NT-proBNP | − 0.07 (− 0.24 to 0.101) | − 0.09 (− 0.25 to 0.09) | 0.04 (− 0.13 to 0.22) |
Hospital discharge | ||||
---|---|---|---|---|
CS | IVCmax | DVAS | NT-proBNP | |
CS | 0.17 (− 0.01 to 0.34) | 0.02 (− 0.16 to 0.2) | 0.17 (− 0.02 to 0.347) | |
IVCmax | 0.17 (− 0.01 to 0.34) | 0.12 (− 0.06 to 0.29) | 0.05 (− 0.13 to 0.24) | |
DVAS | 0.02 (− 0.16 to 0.2) | 0.12 (− 0.06 to 0.29) | 0.05 (− 0.13 to 0.23) | |
NT-proBNP | 0.17 (− 0.02 to 0.347) | 0.05 (− 0.13 to 0.24) | 0.05 (− 0.13 to 0.23) |
Spearman correlation coefficients and respective 95% confidence intervals for congestion marker measures at hospital admission and at hospital discharge based on multiple imputed data. CS clinical congestion score, IVCmax maximum inferior vena cava diameter, NT-proBNP N-terminal pro-B-type natriuretic peptide, DVAS visual analogue scale for dyspnea